BMY Bristol-Myers Squibb Co
Performance
0.39% Past Week
Market Cap
140.58B
Day’s Range
52W Range
Volume (3M)
8.22M
Price-Earnings Ratio
22.69
Revenue
46.16B
Bristol-Myers Squibb Co Latest News



About Bristol-Myers Squibb Co
Bristol-Myers Squibb Company markets, manufactures, licenses, develops, and discovers biopharmaceutical products, including treatments for arthritis, stroke risk reduction, and cancer. Based in New York, the company was founded in 1887 and operates internationally. Stock for Bristol-Myers Squibb is available on the NYSE under the ticker BMY. Keep up to date on the most recent BMY stock news with your eToro watchlist.
Show More34.3K
Employees
New York, New York, US
HQ
1933
Founded
Giovanni Caforio, MD
CEO
Upcoming Earnings
27
APR
REPORTS
Bristol-Myers Squibb Co Q1 2023 earnings report is expected to be released before market open
Consensus
Hold
Price Target
72.00
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
53
Medium
Industry
Avg. 47
64
Environment
64
Social
40
Governance
People Also Bought
- GILD Gilead Sciences Inc 1.22%
- MDT.US Medtronic PLC -2.96%
- CI Cigna Group -5.12%
- ABT Abbott Laboratories 0.19%
- HRL Hormel Foods Corp -0.60%
66.85